MISSING leadership by WHO Director Dr Margaret Chan

Test and treat Hepatitis C now!

Director-General Chan, in 2010, the Executive Board of the World Health Assembly tasked you with mobilizing political will and adequate resources for an effective response to the global viral hepatitis pandemic.

New hepatitis C virus (HCV) drugs coming out of the pipeline have demonstrated cure rates of up to 100%; the hepatitis C virus could feasibly be eradicated from the planet. Without World Health Organization (WHO) at the helm, this prediction will remain unattainable.

Since 2010, more than a million people have died from HCV although it is treatable and curable. Three to four million people are newly infected each year, although HCV is preventable. Most new infections occur among people who inject drugs, yet less than 4% of them have sufficient access to clean injecting equipment. This shocking public health failure allows the epidemic to continue spreading.

Only a tiny fraction of the 185 million people who have HCV are aware of it. Most live in low and middle-income countries (LMICs) and have no access to diagnostics, care, or treatment. Pegylated interferon (PEG-IFN), backbone of the current standard of care for HCV, is priced cruelly out of reach. Where there is access to HCV treatment, people who inject drugs are often denied it: merely 2-4% of people who inject drugs access treatment.

People who inject drugs who want to be treated for HCV are often forced to stop their drug use or enter an opioid substitution therapy (OST) program. Neither of these stipulations are justifiable on clinical grounds, but are forms of discrimination that stem from the moral judgment of people who inject drugs. People who are currently injecting or in an OST program respond as well to HCV treatment as those who are not.

The World Health Organization must act to increase global access to HCV diagnostics and treatment, in particular for people who inject drugs, by:

  • Speaking out frequently on the need for rights-based harm reduction services including needle and syringe programs (NSP), OST and integrated hepatitis C treatment on a scale that will reverse the HCV epidemic among PWID as recommended by WHO/UNAIDS/UNODC.
  • Providing technical support to countries to create access to affordable, high quality, effective and safe biosimilar and alternative pegylated interferon products.
  • Creating clear guidance on HCV screening and testing that explicitly recommends screening for people living with HIV, in whom HCV progresses rapidly, and in people who inject drugs.

Many countries are prepared to address their HCV epidemics, and we, people living with HCV and our advocates, are ready to be actively involved in the development of national plans to prevent and control HCV. Countries are waiting for WHO guidance in key areas that will empower us all to move forward.

You must not fail your mandate. We implore you to demonstrate true leadership through the mobilization of political will and the necessary resources to combat the global HCV epidemic.

Sign on


Attached documents

Document

PDF – 355 kb

1828 supporters

  • FRANCO BRAVO MONICA ADRIANA

    Mexico

  • Frank Michael

    Germany

  • Frank Torsten

    Germany

  • fransz esther

    Medecins du Monde

    Tanzania

  • Frazão Sue

    Brazil

  • Freer Steve

    National Users' Network/Inpud

    United Kingdom

  • Frick Mike

    United States

  • Frieder Kurt

    Fundación Huésped

    Argentina

  • Friederitzi Jonas

    Germany

  • Frings Alexandra

    AIDS-HILFE Aachen e.v.

    Germany

  • Frizon Patrick

    France

  • Frécon Alain

    particulier

    France

  • Förster Christine

    Fixpunkt e.V.

    Germany

  • Gabashvili Imeda

    Open Society Georgia Foundation

    Georgia

  • Gabellini Eileen

    United States

  • gabriel mujimbere

    ANSS

    Burundi

  • galdon azañon teresa

    Spain

  • Gallego Castellví Carlos

    Centro Penitenciario Quatre Camins. Departamento de Justicia, Cataluña

    Spain

  • Gaoussou COULIBALY

    Stop Tuberculose Bouake

    Côte d’Ivoire

  • Garcia Miguel

    Spain

  • Garcia Pablo

    Argentinian Network of Positive People

    Argentina

  • GARCIA Chantal

    France

  • Garcia Udiarraga

    Asociación Itxarobide

    Spain

  • Garcia Lira Martin de Jesus

    Triskel Diverso

    Mexico

  • garcia rodriguez carmen

    pribada

    Spain

  • garcia rodriguez carmen

    persona

    Spain

  • Garcia Serrano Enric

    Spain

  • García Jose A.

    Spain

  • García González-Gordon Humberto

    Spain

  • García Mariño José Francisco

    Spain

  • García Morcillo Diego

    ADHARA

    Spain

  • Gardapkhadze Ekaterine

    aceso internacional for wumen

    Georgia

  • gardapxadze eka

    Aceso international for women

    Georgia

  • Gardini Ivan

    Associazione EPAC onlus

    Italy

  • GARIA PEREZ ANGELES

    ASSCAT

    Spain

  • Garner Kristy

    Heaptitis Victoria

    Australia

  • Gassmann Silvia

    Arud

    Switzerland

  • GASUKU SAMWEL

    MEDECINS DU MONDE

    Tanzania

  • Gatell Abre Pilar

    Spain

  • Gaudette Paul

    United States

  • GAUDRU Carole

    France

  • Gaudré Séverine

    France

  • Generelo Lanaspa Jesús

    Spain

  • genevieve machenaud-lorenzi

    France

  • GEOFFREY COUSIN LECOEUVRE

    AIDES Marseille Belle de Mai

    France

  • George Sarah

    Hepatitis NSW

    Australia

  • George-Svahn Lisa

    Karolinska University Hospital

    Sweden

  • GEORGIANA CRETU

    ABCH GIURGIU

    Romania

  • Georgiev Martin

    European Liver Patients' Association - ELPA

    Bulgaria

  • Gesigora Eva

    Germany